Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 59,912 shares at $32.97 ($2.0M) on 2021-02-23, disclosed to the SEC on 2021-02-25.
Open-market sale of $2.0M KALV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.73 | 800 | $25K | 1.3% |
| 2 | $32.97 | 5,471 | $180K | 9.0% |
| 3 | $32.97 | 5,471 | $180K | 9.0% |
| 4 | $33.72 | 23,441 | $790K | 39.3% |
| 5 | $33.72 | 23,441 | $790K | 39.3% |
| 6 | $35.19 | 1,288 |
| $45K |
| 2.3% |
| Total | $33.59 avg | 59,912 | $2.0M | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |